Speaker Profile
Ph.D., COO, CareDx
Biography
Dr. Marica Grskovic has spent the past two decades building and leading high-performing technology and product development teams across transplant and cell therapy diagnostics. At CareDx, Dr. Grskovic is accountable for strategy and operational oversight of the Testing Services. Prior to CareDx, Dr. Grskovic was a founding scientist at the stem cell-based drug discovery platform technology company iPierian (acquired by BMS), and its spin out True North Therapeutics (acquired by Bioverativ). Dr. Grskovic completed her post-doctoral fellowship on gene regulation in stem cells at University of California San Francisco (UCSF) and holds a PhD in Molecular Biology and Biochemistry from European Molecular Biology Laboratory (EMBL) and University of Heidelberg, Germany.
Clinical Dx Showcase:
CareDx
CareDx is a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the transplant patient journey.
Session Abstract – PMWC 2023 Silicon Valley
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
